Swan Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42K Sell
177
-108
-38% -$22.4K 0.01% 99
2026
Q1
$60.1K Sell
285
-54
-16% -$11.6K 0.02% 68
2025
Q4
$69.8K Sell
339
-196
-37% -$36.9K 0.03% 69
2025
Q3
$84K Hold
535
0.03% 62
2025
Q2
$89.9K Buy
535
+496
+1,272% +$73.6K 0.04% 54
2025
Q1
$5.38K Hold
39
﹤0.01% 186
2024
Q4
$4.6K Buy
+39
New +$4.55K ﹤0.01% 181

Other funds holding CAH

Swan Capital's CAH Position: Q2 2026 in Review

Swan Capital reduced its Cardinal Health (CAH) stake by 38% in Q2 2026, selling an estimated $22.4K and leaving 177 shares worth $42K. The position accounts for 0.01% of the portfolio, ranked #99.

Swan Capital first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. The position peaked at $89.9K in Q2 2025. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Swan Capital held 177 shares of Cardinal Health worth $42K as of Q2 2026.
  • Swan Capital sold 108 Cardinal Health shares in Q2 2026, an estimated $22.4K.
  • Cardinal Health made up 0.01% of Swan Capital's portfolio in Q2 2026, its #99 holding.
  • Swan Capital first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • Swan Capital's Cardinal Health position peaked at $89.9K in Q2 2025.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.